Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)

Site Reference ID/Investigator# 50570, Moscow

Site Reference ID/Investigator# 50567, Moscow

Site Reference ID/Investigator# 50565, Moscow

Site Reference ID/Investigator# 50564, Moscow

Site Reference ID/Investigator# 50547, Saint Petersburg

Site Reference ID/Investigator# 50548, Saint Petersburg

Site Reference ID/Investigator# 50549, Saint Petersburg

Site Reference ID/Investigator# 50551, Saint Petersburg

Site Reference ID/Investigator# 50552, Saint Petersburg

Site Reference ID/Investigator# 50554, Stavropol

Site Reference ID/Investigator# 50580, Stavropol

Site Reference ID/Investigator# 48866, Voronezh

Site Reference ID/Investigator# 54502, Voronezh

Site Reference ID/Investigator# 50562, Volzhskiy, Volgograd Region

Site Reference ID/Investigator# 50555, Saratov

Site Reference ID/Investigator# 50560, Kazan'

Site Reference ID/Investigator# 50561, Izhevsk

Site Reference ID/Investigator# 50556, Samara

Site Reference ID/Investigator# 51643, Chelyabinsk

Site Reference ID/Investigator# 50557, Orenburg

Site Reference ID/Investigator# 62184, Nizhny Novgorod

Site Reference ID/Investigator# 50558, Nizhny Novgorod

Site Reference ID/Investigator# 50545, Perm

Site Reference ID/Investigator# 53156, Perm

Site Reference ID/Investigator# 50563, Yekaterinburg

Site Reference ID/Investigator# 50579, Tyumen

Site Reference ID/Investigator# 50577, Irkutsk

Site Reference ID/Investigator# 50575, Vladivostok